je.st
news
Q+A: Temple Grandin on Zilmax, beta-agonists
2013-08-24 07:17:32| Biotech - Topix.net
Merck and Co. recruited Temple Grandin, an advocate for the humane treatment of livestock, to be on a board that will consult on the company's Zilmax feed additive, which has been temporarily taken off the U.S. and Canadian markets following animal welfare concerns.
Tags: temple
grandin
temple grandin
grandin temple
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|